In the BioHarmony Drug Report Database

"Preview" Icon

Bethanechol

Urecholine (bethanechol) is a small molecule pharmaceutical. Bethanechol was first approved as Urecholine on 1982-01-01. It is used to treat drug-induced abnormalities, gastroesophageal reflux, neurogenic urinary bladder, and urinary retention in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M2 and muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M4, muscarinic acetylcholine receptor M1, and muscarinic acetylcholine receptor M5.

 

Trade Name

 

Urecholine
 

Common Name

 

bethanechol
 

ChEMBL ID

 

CHEMBL1482
 

Indication

 

drug-induced abnormalities, gastroesophageal reflux, neurogenic urinary bladder, urinary retention
 

Drug Class

 

Image (chem structure or protein)

Bethanechol structure rendering